1 / 18

Compensation and Liability for Vaccines The Special Case of Vaccines for Bioterrorism Agents

This article explores the legal and policy implications of vaccines for bioterrorism agents, including issues of consent, liability, compensation, and market considerations. It discusses the challenges posed by limited effectiveness and clinical data, as well as the potential impact on liability and epidemiology. The need for protection for vaccine manufacturers and healthcare providers is also examined, along with the role of compensation in promoting vaccine acceptance. The article concludes by outlining the characteristics of an effective compensation program.

bouffard
Download Presentation

Compensation and Liability for Vaccines The Special Case of Vaccines for Bioterrorism Agents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Compensation and Liability for VaccinesThe Special Case of Vaccines for Bioterrorism Agents Edward P. Richards Director, Program in Law, Science, and Public Health Harvey A. Peltier Professor of Law LSU Law Center Baton Rouge, LA 70803-1000 richards@lsu.edu http://biotech.law.lsu.edu

  2. There is Nothing New Under the Sun • Vaccines for bioterrorism agents pose the extreme cases of vaccine law and policy • Consent versus Mandated Vaccinations • Liability • Compensation • Market issues for one-shot preventive measures • These are still controversial for routine vaccines

  3. Special Problems for Bioterrorism Agents • No effectiveness data • What if it does not work? • Limited clinical data because you will not use them until there is a emergency • Emergency use means poor screening and follow-up • Emergency use means a psychologically loaded environment which is very conducive to epidemic hysterical illness • Timeframe – we are using 30 year old smallpox vaccine - liability can be a time bomb

  4. Why Worry about Liability for Vaccine Manufacturers?

  5. Will They Make the Vaccine without Liability Protections? • Polio – 1950s and 1960s • Swine Flu – 1970s • Childhood Immunizations – 1980s • Bioterrorism Agents – 2000s • Liability is at an all time high • Why might it not matter to a manufacturer?

  6. What if They Will Make the Vaccine without Liability Protections? If the manufacturer will make it without protection, are there other reasons to provide protection?

  7. Is Liability the Basis for Compensation? • What if there is not enough insurance to pay the claims? • What if the manufacturer declares bankruptcy or uses other legal strategies to dodge the liability?

  8. Will Liability Undermine Epidemiology? • The real secret of effect personal injury law • Get clients to friendly doctors for primary treatment • Then all the medical records support your claim • An issue in Swine Flu • The legal system will compensate people without regard to scientific evidence

  9. What about Health Care Providers? • They must have protection or they will not give vaccinations • It must be complete and not dependent on their medical malpractice insurance

  10. Separate Liability from Compensation • If you have a compensation system, fund it separately from liability determinations • The federal government can seek indemnification based on liability if liability is seen as an important market discipline

  11. There is only one effective mechanism to provide complete protection • Substitute the federal government for the defendant • Swine flu • Smallpox (Sec 304) • Federal Community Health Centers • Most all federal employees • This does not prevent the federal government from seeking contribution or indemnification from the manufacturer for bad acts

  12. Compromise Solutions • Federal indemnification • You have to deal with the litigation • Gives a judge the chance to find a reason why the feds do not have to indemnify you • Safety Act • Depends on the secretary’s certification • Could be attacked in court • Allows litigation, which creates chances for the judges to undermine the protections

  13. The Role of Compensation

  14. Why do People Take Vaccines? • People take vaccines when are more frightened of the disease than of the vaccine • People make other people take vaccines when they are more worried about their spreading disease than they are worried about other people’s choices • The purpose of education is to make them more frightened of the disease than the vaccine

  15. Is compensation just a bribe to make the vaccine more attractive? • Smallpox compensation program: • (C) who has volunteered and been selected to be a member of a smallpox emergency response plan described in subparagraph • (B) prior to the time at which the Secretary publicly announces that an active case of smallpox has been identified either within or outside of the United States;

  16. Who Should You Bribe? • Who really cared about compensation? • Hospitals and employers • Not addressed by the smallpox comp program • All benefits are secondary to worker’s comp and insurance benefits • No reimbursement for the benefits costs and other costs to the hospital • 304 Fails this test

  17. What about the Individuals? • Does compensation really make you more likely to take what you see as a dangerous vaccine? • Does a compensation system increase the fear of vaccinations? • Public acceptance of vaccines has not increased after National Childhood Vaccine Injury Compensation Act

  18. What Should a Compensation Program Look Like? • Administrative review • Based on an injury table • Funded by federal funds not tied to the vaccines • All cases reviewed by independent medical examiner, including physical exam in cases based on physical diagnosis • Realistic compensation levels • Reimbursement of third party expenses

More Related